Kemp Dolliver
Stock Analyst at Brookline Capital
(0.54)
# 4,127
Out of 5,182 analysts
19
Total ratings
30.77%
Success rate
-13.1%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSTA Lisata Therapeutics | Downgrades: Hold | n/a | $5.00 | - | 2 | Jan 21, 2026 | |
| RNTX Rein Therapeutics | Downgrades: Hold | n/a | $1.53 | - | 2 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgrades: Buy | $17 | $5.83 | +191.60% | 3 | Dec 18, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $18 | $4.67 | +285.44% | 1 | Jul 21, 2025 | |
| IBIO iBio, Inc. | Initiates: Buy | $3.6 | $2.20 | +63.64% | 1 | Jul 22, 2024 | |
| DARE Daré Bioscience | Upgrades: Buy | $36 | $1.85 | +1,845.95% | 2 | May 15, 2024 | |
| OTLK Outlook Therapeutics | Upgrades: Buy | $31 | $0.22 | +14,031.41% | 1 | Jan 25, 2024 | |
| LNTH Lantheus Holdings | Initiates: Buy | $100 | $81.43 | +22.80% | 1 | Nov 30, 2023 | |
| EDSA Edesa Biotech | Maintains: Buy | $57 | $5.92 | +862.84% | 2 | Oct 12, 2023 | |
| GNLX Genelux | Initiates: Hold | $25 | $2.56 | +876.56% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $6.63 | +182.81% | 1 | Jan 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $8 | $0.99 | +706.45% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5.65 | $0.34 | +1,561.76% | 1 | Feb 2, 2022 |
Lisata Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.00
Upside: -
Rein Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $1.53
Upside: -
Verrica Pharmaceuticals
Dec 18, 2025
Upgrades: Buy
Price Target: $17
Current: $5.83
Upside: +191.60%
Radiopharm Theranostics
Jul 21, 2025
Initiates: Buy
Price Target: $18
Current: $4.67
Upside: +285.44%
iBio, Inc.
Jul 22, 2024
Initiates: Buy
Price Target: $3.6
Current: $2.20
Upside: +63.64%
Daré Bioscience
May 15, 2024
Upgrades: Buy
Price Target: $36
Current: $1.85
Upside: +1,845.95%
Outlook Therapeutics
Jan 25, 2024
Upgrades: Buy
Price Target: $31
Current: $0.22
Upside: +14,031.41%
Lantheus Holdings
Nov 30, 2023
Initiates: Buy
Price Target: $100
Current: $81.43
Upside: +22.80%
Edesa Biotech
Oct 12, 2023
Maintains: Buy
Price Target: $57
Current: $5.92
Upside: +862.84%
Genelux
May 18, 2023
Initiates: Hold
Price Target: $25
Current: $2.56
Upside: +876.56%
Jan 13, 2023
Initiates: Buy
Price Target: $19
Current: $6.63
Upside: +182.81%
Oct 21, 2022
Assumes: Buy
Price Target: $8
Current: $0.99
Upside: +706.45%
Feb 2, 2022
Initiates: Buy
Price Target: $5.65
Current: $0.34
Upside: +1,561.76%